Virginie Durbecq - Concepedia

Author

Virginie Durbecq

Institut Jules Bordet

Also Known As

V Durbecq, V. Durbecq, Virginie Durbecq

109

Publications

4.2K

Citations

H-Index

Concepts

All Affiliations

Institut Jules Bordet Université Libre de Bruxelles Vrije Universiteit Brussel Hospital of Prato John Radcliffe Hospital

About

Virginie Durbecq is an author at Institut Jules Bordet specializing in medicine, breast cancer, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	17	859
2	Health Sciences	4	4	129
3	Engineering	2	2	72
4	Biochemistry	1	1	89
5	Biomedical Engineering	1	1	19

Virginie Durbecq

Publications

Citations

H-Index

Page 1

	Year	Citations
<i>PIK3CA</i>mutations associated with gene signature of low mTORC1 signaling and better outcomes in estrogen receptor–positive breast cancer Sherene Loi, Benjamin Haibe‐Kains, Samira Majjaj, Proceedings of the National Academy of Sciences	2010	349
A Five-Gene Molecular Grade Index and <i>HOXB13:IL17BR</i> Are Complementary Prognostic Factors in Early Stage Breast Cancer Xiaojun Ma, Ranelle Salunga, Sonika Dahiya, Clinical Cancer Research	2008	308
HER2-Positive Circulating Tumor Cells in Breast Cancer Michail Ignatiadis, Françoise Rothé, Carole Chaboteaux, PLoS ONE	2011	205
Use of cancer‐specific genomic rearrangements to quantify disease burden in plasma from patients with solid tumors David J. McBride, Arto Orpana, Christos Sotiriou, Genes Chromosomes and Cancer	2010	194
Multifactorial Approach to Predicting Resistance to Anthracyclines Christine Desmedt, Angelo Di Leo, Evandro de Azambuja, Journal of Clinical Oncology	2011	187
HER-2/neu as a Predictive Marker in a Population of Advanced Breast Cancer Patients Randomly Treated Either with Single-agent Doxorubicin or Single-agent Docetaxel Angelo Di Leo, Stephen Chan, Marianne Paesmans, Breast Cancer Research and Treatment Breast OncologySingle-agent DocetaxelMedicinePathologySingle-agent Doxorubicin	2004	138
Polysomy 17 in HER-2/neu Status Elaboration in Breast Cancer: Effect on Daily Practice Yan Ma, Laurence Lespagnard, Virginie Durbecq, Clinical Cancer Research	2005	111
Topoisomerase-IIα expression as a predictive marker in a population of advanced breast cancer patients randomly treated either with single-agent doxorubicin or single-agent docetaxel Virginie Durbecq, Marianne Paesmans, Fátima Cardoso, Molecular Cancer Therapeutics Topo-ii StatusTumor BiologyDoxorubicin ArmBreast OncologyTopoisomerase-iiα Expression	2004	93
Correlation between complete response to anthracycline-based chemotherapy and topoisomerase II-α gene amplification and protein overexpression in locally advanced/metastatic breast cancer Fátima Cardoso, Virginie Durbecq, Denis Larsimont, International Journal of Oncology	2004	90
Crystal structure of isopentenyl diphosphate:dimethylallyl diphosphate isomerase Virginie Durbecq The EMBO Journal Crystal StructureBiochemistryProtein X-ray CrystallographyStructure-function Enzyme KineticsStructural Biology	2001	89

Page 1